Search Results - "Aliazis, Konstantinos"
-
1
Immune-related adverse effects of checkpoint immunotherapy and implications for the treatment of patients with cancer and autoimmune diseases
Published in Frontiers in immunology (05-06-2023)“…During the past decade, there has been a revolution in cancer therapeutics by the emergence of antibody-based immunotherapies that modulate immune responses…”
Get full text
Journal Article -
2
The Putative Roles and Functions of Indel, Repetition and Duplication Events in Alphavirus Non-Structural Protein 3 Hypervariable Domain (nsP3 HVD) in Evolution, Viability and Re-Emergence
Published in Viruses (28-05-2021)“…Alphavirus non-structural proteins 1–4 (nsP1, nsP2, nsP3, and nsP4) are known to be crucial for alphavirus RNA replication and translation. To date, nsP3 has…”
Get full text
Journal Article -
3
Emergency myelopoiesis in solid cancers
Published in British journal of haematology (01-09-2024)“…Summary Cells of the innate and adaptive immune systems are the progeny of haematopoietic stem and progenitor cells (HSPCs). During steady‐state myelopoiesis,…”
Get full text
Journal Article -
4
Pparβ/δ Has an Indispensable Role in T Cell Function and Anti-Tumor Responses
Published in Blood (02-11-2023)“…The peroxisome proliferator-activated receptors (PPARs) are a group of transcriptional factor of the nuclear hormone receptor superfamily, which promote…”
Get full text
Journal Article -
5
PD-1 Expression By Dendritic Cells Is a Key Regulator of T-Cell Immunity in Cancer
Published in Blood (02-11-2023)“…Programmed cell death 1 (PD-1) is an inhibitory receptor expressed on a variety of immune cells and a therapeutic target of checkpoint immunotherapy for cancer…”
Get full text
Journal Article -
6
Specific PD-1 Deletion on Regulatory T Cells Leads to Enhanced Anti-Tumor Responses
Published in Blood (02-11-2023)“…Programmed cell death 1 (PD-1) is a T cell inhibitory receptor and the most extensively exploited therapeutic target of checkpoint immunotherapy in cancer…”
Get full text
Journal Article -
7
Immune cellular components and signaling pathways in the tumor microenvironment
Published in Seminars in cancer biology (01-11-2022)“…During the past decade there has been a revolution in cancer therapeutics by the emergence of antibody-based and cell-based immunotherapies that modulate…”
Get full text
Journal Article -
8
42243 RIAM regulates T cell migration and activation in melanoma
Published in Journal of the American Academy of Dermatology (01-09-2023)Get full text
Journal Article -
9
SHP-2 and PD-1-SHP-2 signaling regulate myeloid cell differentiation and antitumor responses
Published in Nature immunology (01-01-2023)“…The inhibitory receptor PD-1 suppresses T cell activation by recruiting the phosphatase SHP-2. However, mice with a T-cell-specific deletion of SHP-2 do not…”
Get full text
Journal Article -
10
A four-cell pathway orchestrated by Flt3-L-dependent cDCs controls anti-tumor responses
Published in Cell reports. Medicine (16-01-2024)“…A study by Régnier et al. shows that Flt3-ligand (FL) levels program two distinct mechanisms of anti-tumor immunity. Low FL levels allow recruitment of T…”
Get full text
Journal Article -
11
SHP-2 Regulates Myeloid Cell Differentiation, Anti-Tumor Responses and Innate Immune Memory
Published in Blood (15-11-2022)Get full text
Journal Article -
12
The human liver microenvironment shapes the homing and function of CD4 + T-cell populations
Published in Gut (01-07-2022)“…Tissue-resident memory T cells (T ) are vital immune sentinels that provide protective immunity. While hepatic CD8 T have been well described, little is known…”
Get more information
Journal Article -
13
The effect of pharmacological cessation and restoration of menstrual cycle on bone metabolism in premenopausal women with endometriosis
Published in Bone (New York, N.Y.) (01-05-2022)“…GnRH-analogs induce bone loss. We aimed to investigate the effects of goserelin-induced menstrual cessation (MC) and subsequent menstrual restoration (MR) on…”
Get full text
Journal Article -
14
Driver Mutations Dictate the Immunologic Landscape and Response to Checkpoint Immunotherapy of Glioblastoma
Published in Cancer immunology research (03-05-2023)“…The composition of the tumor immune microenvironment (TIME) is considered a key determinant of patients' response to immunotherapy. The mechanisms underlying…”
Get more information
Journal Article -
15
In Vitro and Ex Vivo Models to Study T Cell Migration Through the Human Liver Parenchyma
Published in Methods in molecular biology (Clifton, N.J.) (01-01-2017)“…The liver is the largest internal organ and filters around 3 pints of blood per minute. This continuous flux of blood should not be confused with rapid egress…”
Get more information
Journal Article